Non-antithrombotic Therapy After Transcatheter Aortic Valve Implantation Trial
Conditions
Aortic Stenosis · TAVI(Transcatheter Aortic Valve Implantation) · Aspirin · DAPT(Dual Antiplatelet Therapy) · SAPT(Single Antiplatelet Therapy)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Keio University Hospital, Shinjuku, Tokyo, Japan
Contact: Study coordinator (Masanori Yamamoto)Contact: Study coordinator (Tetsuro Shimura)Contact: Study coordinator (Takahiro Tokuda)Contact: Study coordinator (Masahiko Noguchi)Contact: Study coordinator (Hiroshi Ueno)Contact: Study coordinator (Hiroto Suzuyama)Contact: Study coordinator (Masahiko Asami)Contact: Study coordinator (Shinichi Shirai)Contact: Study coordinator (Yusuke Watanabe)Contact: Study coordinator (Kouhei Yamaguchi)Contact: Study coordinator (Norio Tada)Contact: Study coordinator (Futoshi Yamanaka)Contact: Study coordinator (Yohei Ohno)Contact: Study coordinator (Masaki Izumo)Contact: Study coordinator (Kazumasa Yamasaki)Contact: Study coordinator (Hidetaka Nishina)Contact: Study coordinator (Yasushi Fuku)Contact: Study coordinator (Gaku Nakazawa)Contact: Study coordinator (Fumiaki Yashima)
Study leads
Yosuke Sawa
Study Director
EPS Corporation